# FDA Inspection 1248882 - Qingdao Kangyuan Pharmaceutical Co. Ltd. - August 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/qingdao-kangyuan-pharmaceutical-co-ltd/8f056438-4532-4da2-a2a2-1d3c3c2b65f0
Source feed: FDA_Inspections

> FDA Inspection 1248882 for Qingdao Kangyuan Pharmaceutical Co. Ltd. on August 16, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1248882
- Company Name: Qingdao Kangyuan Pharmaceutical Co. Ltd.
- Inspection Date: 2024-08-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 971315 - 2016-04-22](https://www.keypedia.com/records/fda_inspections/qingdao-kangyuan-pharmaceutical-co-ltd/9aaa547e-a451-4766-a974-84ae76082dd6)
- [FDA Inspection 819155 - 2013-01-25](https://www.keypedia.com/records/fda_inspections/qingdao-kangyuan-pharmaceutical-co-ltd/6c3a03d4-4e4a-415e-89c0-79b97e03e495)

Company: https://www.keypedia.com/companies/qingdao-kangyuan-pharmaceutical-co-ltd/8d3cd5ff-f332-4315-b8ad-efc53734f628

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c